Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour

Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a sup...

Full description

Saved in:
Bibliographic Details
Published inNPJ precision oncology Vol. 2; no. 1; p. 26
Main Authors Malara, N., Gentile, F., Coppedè, N., Coluccio, M. L., Candeloro, P., Perozziello, G., Ferrara, L., Giannetto, M., Careri, M., Castellini, A., Mignogna, C., Presta, I., Pirrone, C. K., Maisano, D., Donato, A., Donato, G., Greco, M., Scumaci, D., Cuda, G., Casale, F., Ferraro, E., Bonacci, S., Trunzo, V., Mollace, V., Onesto, V., Majewska, R., Amato, F., Renne, M., Innaro, N., Sena, G., Sacco, R., Givigliano, F., Voci, C., Volpentesta, G., Guzzi, G., Lavano, A., Scali, E., Bottoni, U., Di Fabrizio, E.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 19.11.2018
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN2397-768X
2397-768X
DOI10.1038/s41698-018-0069-7

Cover

Abstract Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations. Diagnostics: Proton state of secreted proteins in blood helps identify cancer A blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio 
from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer.
AbstractList Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual's diagnosis and/or help clarify risk in healthy populations.Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual's diagnosis and/or help clarify risk in healthy populations.
Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations. A blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio 
from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer.
Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations.
Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations. Diagnostics: Proton state of secreted proteins in blood helps identify cancer A blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio 
from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer.
Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations.Diagnostics: Proton state of secreted proteins in blood helps identify cancerA blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio 
from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer.
ArticleNumber 26
Author Mollace, V.
Onesto, V.
Scali, E.
Bonacci, S.
Innaro, N.
Castellini, A.
Coppedè, N.
Gentile, F.
Perozziello, G.
Volpentesta, G.
Donato, A.
Ferrara, L.
Givigliano, F.
Sena, G.
Malara, N.
Casale, F.
Candeloro, P.
Maisano, D.
Donato, G.
Sacco, R.
Giannetto, M.
Scumaci, D.
Coluccio, M. L.
Majewska, R.
Lavano, A.
Ferraro, E.
Greco, M.
Renne, M.
Trunzo, V.
Guzzi, G.
Amato, F.
Bottoni, U.
Mignogna, C.
Di Fabrizio, E.
Voci, C.
Careri, M.
Presta, I.
Cuda, G.
Pirrone, C. K.
Author_xml – sequence: 1
  givenname: N.
  orcidid: 0000-0002-1719-293X
  surname: Malara
  fullname: Malara, N.
  email: nataliamalara@unicz.it
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 2
  givenname: F.
  surname: Gentile
  fullname: Gentile, F.
  organization: Department of Electrical Engineering and Information Technology, University Federico II
– sequence: 3
  givenname: N.
  orcidid: 0000-0001-5715-4236
  surname: Coppedè
  fullname: Coppedè, N.
  organization: Institute of Materials for Electronics and Magnetism IMEM CNR Parco Area delle Scienze
– sequence: 4
  givenname: M. L.
  orcidid: 0000-0002-9987-2348
  surname: Coluccio
  fullname: Coluccio, M. L.
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 5
  givenname: P.
  surname: Candeloro
  fullname: Candeloro, P.
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 6
  givenname: G.
  surname: Perozziello
  fullname: Perozziello, G.
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 7
  givenname: L.
  surname: Ferrara
  fullname: Ferrara, L.
  organization: Centre of Medical Physics and Biomedical Engineering, Medical University of Vienna
– sequence: 8
  givenname: M.
  surname: Giannetto
  fullname: Giannetto, M.
  organization: Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma
– sequence: 9
  givenname: M.
  surname: Careri
  fullname: Careri, M.
  organization: Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma
– sequence: 10
  givenname: A.
  surname: Castellini
  fullname: Castellini, A.
  organization: Institute of Materials for Electronics and Magnetism IMEM CNR Parco Area delle Scienze
– sequence: 11
  givenname: C.
  orcidid: 0000-0001-5576-4946
  surname: Mignogna
  fullname: Mignogna, C.
  organization: Department of Health Science, University Magna Graecia
– sequence: 12
  givenname: I.
  surname: Presta
  fullname: Presta, I.
  organization: Department of Health Science, University Magna Graecia
– sequence: 13
  givenname: C. K.
  surname: Pirrone
  fullname: Pirrone, C. K.
  organization: Department of Health Science, University Magna Graecia
– sequence: 14
  givenname: D.
  surname: Maisano
  fullname: Maisano, D.
  organization: Department of Health Science, University Magna Graecia
– sequence: 15
  givenname: A.
  surname: Donato
  fullname: Donato, A.
  organization: Department of Health Science, University Magna Graecia
– sequence: 16
  givenname: G.
  surname: Donato
  fullname: Donato, G.
  organization: Department of Health Science, University Magna Graecia
– sequence: 17
  givenname: M.
  surname: Greco
  fullname: Greco, M.
  organization: Department of Health Science, University Magna Graecia
– sequence: 18
  givenname: D.
  surname: Scumaci
  fullname: Scumaci, D.
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 19
  givenname: G.
  orcidid: 0000-0001-6313-1866
  surname: Cuda
  fullname: Cuda, G.
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 20
  givenname: F.
  surname: Casale
  fullname: Casale, F.
  organization: Department of Health Science, University Magna Graecia
– sequence: 21
  givenname: E.
  surname: Ferraro
  fullname: Ferraro, E.
  organization: Department of Clinical and Biological Sciences, University of Torino
– sequence: 22
  givenname: S.
  surname: Bonacci
  fullname: Bonacci, S.
  organization: Department of Health Science, University Magna Graecia
– sequence: 23
  givenname: V.
  surname: Trunzo
  fullname: Trunzo, V.
  organization: Department of Health Science, University Magna Graecia
– sequence: 24
  givenname: V.
  surname: Mollace
  fullname: Mollace, V.
  organization: Department of Health Science, University Magna Graecia
– sequence: 25
  givenname: V.
  orcidid: 0000-0002-2308-4126
  surname: Onesto
  fullname: Onesto, V.
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 26
  givenname: R.
  surname: Majewska
  fullname: Majewska, R.
  organization: School of Biological Sciences, North-West University
– sequence: 27
  givenname: F.
  surname: Amato
  fullname: Amato, F.
  organization: Department of Experimental and Clinical Medicine, University Magna Graecia
– sequence: 28
  givenname: M.
  surname: Renne
  fullname: Renne, M.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 29
  givenname: N.
  surname: Innaro
  fullname: Innaro, N.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 30
  givenname: G.
  orcidid: 0000-0001-9793-3250
  surname: Sena
  fullname: Sena, G.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 31
  givenname: R.
  surname: Sacco
  fullname: Sacco, R.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 32
  givenname: F.
  surname: Givigliano
  fullname: Givigliano, F.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 33
  givenname: C.
  surname: Voci
  fullname: Voci, C.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 34
  givenname: G.
  surname: Volpentesta
  fullname: Volpentesta, G.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 35
  givenname: G.
  surname: Guzzi
  fullname: Guzzi, G.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 36
  givenname: A.
  surname: Lavano
  fullname: Lavano, A.
  organization: Department of Surgical and Medical Science University Magna Graecia
– sequence: 37
  givenname: E.
  surname: Scali
  fullname: Scali, E.
  organization: Department of Health Science, University Magna Graecia
– sequence: 38
  givenname: U.
  surname: Bottoni
  fullname: Bottoni, U.
  organization: Department of Health Science, University Magna Graecia
– sequence: 39
  givenname: E.
  surname: Di Fabrizio
  fullname: Di Fabrizio, E.
  email: Enzo.DiFabrizio@KAUST.EDU
  organization: Physical Science & Engineering Division, King Abdullah University of Science and Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30480095$$D View this record in MEDLINE/PubMed
BookMark eNqNkUFv1DAQhSNUREvpD-CCLHHhEnCcxLEvSKiigFSJAyBxsybJpOuS2MHjFC2n_nQcdqGlEoiDZcv-3vPMm4fZgfMOs-xxwZ8XvFQvqCqkVjkv0uJS58297EiUuskbqT4f3DofZidEl5wnsi6ElA-yw5JXinNdH2XXH5YZw2bbBz9vfGs7NkKbe5d3GzuzCYGWgMQIu4DRT8jm4KN3EK13jCJEZOD69fbK9gkEluwoAaP9jj0Llr4wIEKiCV1kfmA0-wB9-iguk1_Co-z-ACPhyX4_zj6dvf54-jY_f__m3emr87yrGh5zOYiiUjVIUIPqZKuE0EOJ2NZ9JZtWtkNX1whDKZu65VooAcCFxqpGXQ0CyuNM7HwXN8P2G4yjmYOdIGxNwc2aqNklalJOZk3UNEn0cieal3bCvkstBLgRerDmzxdnN-bCXxkpKqHr1eDZ3iD4rwtSNJOlDscRHPqFjChKJUutS5nQp3fQyxRPCjJRpdKNSANcDZ_cruh3Kb8mmoBiB3TBEwUc_qvN5o6ms_HniFNTdvyncp8qpV_cBYabov8u-gHS89lQ
CitedBy_id crossref_primary_10_1016_j_addr_2020_09_011
crossref_primary_10_3390_nano11092432
crossref_primary_10_1002_cam4_4813
crossref_primary_10_1016_j_esmorw_2024_100046
crossref_primary_10_1016_j_trac_2019_05_043
crossref_primary_10_1186_s11671_021_03489_z
crossref_primary_10_1111_wrr_13251
crossref_primary_10_18632_oncotarget_27990
crossref_primary_10_1021_acsami_1c15981
crossref_primary_10_1155_2021_8841911
crossref_primary_10_1109_JSEN_2019_2940993
crossref_primary_10_3390_ijms21134711
crossref_primary_10_3389_fonc_2021_737730
crossref_primary_10_3390_mi11020123
crossref_primary_10_1016_j_orgel_2019_105579
crossref_primary_10_3390_cancers14194676
Cites_doi 10.1021/bi101933p
10.1016/j.bbadis.2003.08.002
10.3389/fonc.2015.00115
10.1038/srep18992
10.1016/j.orgel.2016.05.001
10.1038/s41467-017-01174-3
10.3390/ijms18091852
10.1002/smll.201201377
10.1155/2014/302694
10.1371/journal.pone.0129762
10.1038/srep24517
10.1126/science.1242072
10.1016/j.mee.2013.01.036
10.1021/ja055762e
10.1073/pnas.1719264115
10.3322/caac.21443
10.1088/0957-4484/25/48/485703
10.1186/s12967-016-0876-y
10.1021/pr2012347
10.1016/S0378-4274(99)00160-5
10.1038/533304a
10.1006/niox.1997.0141
10.1038/srep04297
ContentType Journal Article
Copyright The Author(s) 2018
The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2018
– notice: The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOI 10.1038/s41698-018-0069-7
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef

PubMed
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2397-768X
ExternalDocumentID 10.1038/s41698-018-0069-7
PMC6242957
30480095
10_1038_s41698_018_0069_7
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID 0R~
53G
7RV
7X7
8FI
8FJ
AAJSJ
AAKAB
ABUWG
ACGFS
ACSMW
ADBBV
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
C6C
CCPQU
EBLON
EBS
EJD
FYUFA
GROUPED_DOAJ
HMCUK
HYE
M~E
NAO
NAPCQ
NO~
OK1
PGMZT
PIMPY
RNT
RPM
SNYQT
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
PPXIY
PUEGO
EMOBN
KQ8
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c470t-6f21485a6a8f8c6b8229f3eeb5d467b6bfc55eaf3675b09282aa029e45e94f2a3
IEDL.DBID BENPR
ISSN 2397-768X
IngestDate Wed Aug 20 00:04:23 EDT 2025
Tue Sep 30 16:57:14 EDT 2025
Wed Oct 01 14:06:52 EDT 2025
Fri Jul 25 04:51:42 EDT 2025
Wed Feb 19 02:42:15 EST 2025
Thu Apr 24 22:59:36 EDT 2025
Wed Oct 01 00:59:44 EDT 2025
Fri Feb 21 02:39:57 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-6f21485a6a8f8c6b8229f3eeb5d467b6bfc55eaf3675b09282aa029e45e94f2a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1719-293X
0000-0002-9987-2348
0000-0001-5715-4236
0000-0002-2308-4126
0000-0001-5576-4946
0000-0001-9793-3250
0000-0001-6313-1866
OpenAccessLink https://www.proquest.com/docview/2389720017?pq-origsite=%requestingapplication%&accountid=15518
PMID 30480095
PQID 2389720017
PQPubID 4669714
ParticipantIDs unpaywall_primary_10_1038_s41698_018_0069_7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6242957
proquest_miscellaneous_2138639936
proquest_journals_2389720017
pubmed_primary_30480095
crossref_primary_10_1038_s41698_018_0069_7
crossref_citationtrail_10_1038_s41698_018_0069_7
springer_journals_10_1038_s41698_018_0069_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-11-19
PublicationDateYYYYMMDD 2018-11-19
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-11-19
  day: 19
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle NPJ precision oncology
PublicationTitleAbbrev npj Precision Onc
PublicationTitleAlternate NPJ Precis Oncol
PublicationYear 2018
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Malara (CR11) 2014; 28
Rodriguez, Laio (CR19) 2014; 344
AA (CR27) 2005; 127
Tsai (CR3) 2016; 6
Coppedè (CR18) 2014; 25
Kalapos (CR9) 1999; 110
Tamae, Lim, Wuenschell, Termini (CR10) 2011; 50
Raso (CR22) 2012; 11
Brady (CR6) 2017; 8
Gentile (CR13) 2014; 2014
Limongi (CR26) 2013; 9
Kaiser (CR4) 2018; 19
Hong (CR5) 2018; 10
Malara (CR12) 2016; 14
Heidi (CR2) 2016; 533
Gentile (CR17) 2013; 111
Gaudry-Talarmain (CR24) 2002; 1
Gentile (CR14) 2016; 6
Gentile (CR16) 2016; 35
Carrera, Hagop, Blinder (CR1) 2018; 68
Malara (CR8) 2016; 1
CR20
Vizoso, Eiro, Cid, Schneider, Perez-Fernandez (CR7) 2017; 18
Coppedè, Villani, Gentile (CR15) 2014; 4
Ahmed (CR23) 2003; 1639
Scumaci (CR25) 2015; 10
Wagner, Wiig (CR21) 2015; 5
NM Malara (69_CR11) 2014; 28
FML Gentile (69_CR17) 2013; 111
N Coppedè (69_CR18) 2014; 25
PM Carrera (69_CR1) 2018; 68
A Rodriguez (69_CR19) 2014; 344
69_CR20
Yu AA (69_CR27) 2005; 127
F Gentile (69_CR14) 2016; 6
D Scumaci (69_CR25) 2015; 10
N Malara (69_CR12) 2016; 14
L Heidi (69_CR2) 2016; 533
F Gentile (69_CR16) 2016; 35
YM Gaudry-Talarmain (69_CR24) 2002; 1
FJ Vizoso (69_CR7) 2017; 18
MP Kalapos (69_CR9) 1999; 110
D Tamae (69_CR10) 2011; 50
F Gentile (69_CR13) 2014; 2014
M Wagner (69_CR21) 2015; 5
WS Tsai (69_CR3) 2016; 6
N Ahmed (69_CR23) 2003; 1639
N Coppedè (69_CR15) 2014; 4
N Malara (69_CR8) 2016; 1
X Hong (69_CR5) 2018; 10
C Raso (69_CR22) 2012; 11
T Limongi (69_CR26) 2013; 9
J Kaiser (69_CR4) 2018; 19
SW Brady (69_CR6) 2017; 8
27176720 - J Transl Med. 2016 May 12;14(1):133
26061043 - PLoS One. 2015 Jun 10;10(6):e0129762
28841158 - Int J Mol Sci. 2017 Aug 25;18(9):null
14559119 - Biochim Biophys Acta. 2003 Oct 15;1639(2):121-32
9441905 - Nitric Oxide. 1997 Aug;1(4):330-45
23027505 - Small. 2013 Feb 11;9(3):402-12
27193658 - Nature. 2016 May 18;533(7603):304-5
27075165 - Sci Rep. 2016 Apr 14;6:24517
26753611 - Sci Rep. 2016 Jan 12;6:18992
26075182 - Front Oncol. 2015 May 26;5:115
29338071 - CA Cancer J Clin. 2018 Mar;68(2):153-165
24599076 - Sci Rep. 2014 Mar 06;4:4297
10597025 - Toxicol Lett. 1999 Nov 22;110(3):145-75
24579079 - Biomed Res Int. 2014;2014:302694
16316209 - J Am Chem Soc. 2005 Dec 7;127(48):16774-5
29348215 - Science. 2018 Jan 19;359(6373):259
21355561 - Biochemistry. 2011 Mar 29;50(12):2321-9
22563702 - J Proteome Res. 2012 Jun 1;11(6):3199-210
24970081 - Science. 2014 Jun 27;344(6191):1492-6
25388936 - Nanotechnology. 2014 Dec 5;25(48):485703
29093439 - Nat Commun. 2017 Nov 1;8(1):1231
25620181 - J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):717-31
29453278 - Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2467-2472
References_xml – volume: 50
  start-page: 2321
  year: 2011
  end-page: 2329
  ident: CR10
  article-title: Mutagenesis and repair induced by the DNA advanced glycation end product N2-1-(carboxyethyl)-2′- deoxyguanosine in human cells
  publication-title: Biochemistry
  doi: 10.1021/bi101933p
– volume: 1639
  start-page: 121
  year: 2003
  end-page: 132
  ident: CR23
  article-title: Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2003.08.002
– volume: 5
  start-page: 115
  year: 2015
  ident: CR21
  article-title: Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2015.00115
– volume: 6
  start-page: 1
  year: 2016
  end-page: 15
  ident: CR14
  article-title: Geometrical patterning of super-hydrophobic biosensing transistors enables space and time resolved analysis of biological mixtures
  publication-title: Sci. Rep.
  doi: 10.1038/srep18992
– volume: 35
  start-page: 59
  year: 2016
  end-page: 64
  ident: CR16
  article-title: A theoretical model for the time varying current in organic electrochemical transistors in a dynamic regime Organic Electronics
  publication-title: Org. Electron.
  doi: 10.1016/j.orgel.2016.05.001
– volume: 19
  start-page: 359
  year: 2018
  end-page: 259
  ident: CR4
  article-title: Liquid biopsy’ for cancer promises early detection
  publication-title: Science
– volume: 28
  start-page: 717
  year: 2014
  end-page: 731
  ident: CR11
  article-title: In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patients
  publication-title: J. Biol. Regul. Homeost. Agents
– volume: 8
  year: 2017
  ident: CR6
  article-title: Combating subclonal evolution of resistant cancer phenotypes
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-01174-3
– volume: 4
  start-page: 1
  year: 2014
  end-page: 7
  ident: CR15
  article-title: Diffusion driven selectivity in organic electrochemical transistors
  publication-title: Sci. Rep.
– volume: 18
  start-page: 1852
  year: 2017
  ident: CR7
  article-title: Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms18091852
– volume: 9
  start-page: 402
  year: 2013
  end-page: 412
  ident: CR26
  article-title: Nanostructured superhydrophobic substrates trigger the development of 3D neuronal networks
  publication-title: Small
  doi: 10.1002/smll.201201377
– volume: 2014
  start-page: 1
  year: 2014
  end-page: 10
  ident: CR13
  article-title: Microtexturing of the conductive PEDOT: PSS polymer for superhydrophobic organic electrochemical transistors
  publication-title: Biomed. Res. Int.
  doi: 10.1155/2014/302694
– volume: 10
  year: 2015
  ident: CR25
  article-title: Plasma proteomic profiling in hereditary breast cancer reveals a BRCA1-specific signature: diagnostic and functional implications
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0129762
– volume: 6
  year: 2016
  ident: CR3
  article-title: Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients
  publication-title: Sci. Rep.
  doi: 10.1038/srep24517
– volume: 344
  start-page: 1492
  year: 2014
  end-page: 1496
  ident: CR19
  article-title: Clustering by fast search and find of density peaks
  publication-title: Science
  doi: 10.1126/science.1242072
– volume: 111
  start-page: 272
  year: 2013
  end-page: 276
  ident: CR17
  article-title: Non periodic patterning of super-hydrophobic surfaces forthe manipulation of few molecules
  publication-title: Microelectron. Eng.
  doi: 10.1016/j.mee.2013.01.036
– volume: 127
  start-page: 16774
  year: 2005
  end-page: 16775
  ident: CR27
  article-title: resolution printing of DNA feature on poly(methyl methacrylate) substrates using supramolecular nano-stamping
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja055762e
– volume: 10
  start-page: 2467
  year: 2018
  end-page: 2472
  ident: CR5
  article-title: Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1719264115
– volume: 68
  start-page: 153
  year: 2018
  end-page: 165
  ident: CR1
  article-title: The financial burden and distress of patients with cancer: understanding and stepping‐up action on the financial toxicity of cancer treatment
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21443
– volume: 25
  start-page: 485703
  year: 2014
  ident: CR18
  article-title: Titanyl phthalocyanine ambipolar thin film transistors making use of carbon nanotube electrodes
  publication-title: Nanotechnology
  doi: 10.1088/0957-4484/25/48/485703
– volume: 14
  year: 2016
  ident: CR12
  article-title: Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provided useful biomarker for personalized metastatic risk assessment
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-016-0876-y
– volume: 11
  start-page: 3199
  year: 2012
  end-page: 3210
  ident: CR22
  article-title: Characterization of breast cancer interstitial fluids by TmT labeling, LTQOrbitrap Velos mass spectrometry, and pathway analysis
  publication-title: J. Proteome Res.
  doi: 10.1021/pr2012347
– volume: 1
  start-page: 3545
  year: 2016
  end-page: 3552
  ident: CR8
  article-title: Tailoring super- hydrophobic properties of electrochemical biosensor for early cancer detection
  publication-title: Soft Mater. Biomater.
– volume: 110
  start-page: 145
  year: 1999
  end-page: 175
  ident: CR9
  article-title: Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications
  publication-title: Toxicol. Lett.
  doi: 10.1016/S0378-4274(99)00160-5
– volume: 533
  start-page: 304
  year: 2016
  end-page: 305
  ident: CR2
  article-title: Bankruptcy of nanomedicine firm worries drug developers
  publication-title: Nature
  doi: 10.1038/533304a
– volume: 1
  start-page: 330
  year: 2002
  end-page: 345
  ident: CR24
  article-title: Nitric oxide and peroxynitrite affect differently acetylcholine release, choline acetyltransferase activity, synthesis, and compartmentation of newly formed acetylcholine in Torpedo marmorata synaptosomes
  publication-title: Nitric Oxide-Biol. Chem.
  doi: 10.1006/niox.1997.0141
– ident: CR20
– volume: 28
  start-page: 717
  year: 2014
  ident: 69_CR11
  publication-title: J. Biol. Regul. Homeost. Agents
– volume: 111
  start-page: 272
  year: 2013
  ident: 69_CR17
  publication-title: Microelectron. Eng.
  doi: 10.1016/j.mee.2013.01.036
– volume: 533
  start-page: 304
  year: 2016
  ident: 69_CR2
  publication-title: Nature
  doi: 10.1038/533304a
– volume: 4
  start-page: 1
  year: 2014
  ident: 69_CR15
  publication-title: Sci. Rep.
  doi: 10.1038/srep04297
– volume: 19
  start-page: 359
  year: 2018
  ident: 69_CR4
  publication-title: Science
– volume: 10
  start-page: 2467
  year: 2018
  ident: 69_CR5
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1719264115
– volume: 1
  start-page: 3545
  year: 2016
  ident: 69_CR8
  publication-title: Soft Mater. Biomater.
– volume: 1639
  start-page: 121
  year: 2003
  ident: 69_CR23
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2003.08.002
– volume: 5
  start-page: 115
  year: 2015
  ident: 69_CR21
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2015.00115
– volume: 68
  start-page: 153
  year: 2018
  ident: 69_CR1
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21443
– volume: 25
  start-page: 485703
  year: 2014
  ident: 69_CR18
  publication-title: Nanotechnology
  doi: 10.1088/0957-4484/25/48/485703
– volume: 35
  start-page: 59
  year: 2016
  ident: 69_CR16
  publication-title: Org. Electron.
  doi: 10.1016/j.orgel.2016.05.001
– volume: 14
  year: 2016
  ident: 69_CR12
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-016-0876-y
– ident: 69_CR20
– volume: 6
  start-page: 1
  year: 2016
  ident: 69_CR14
  publication-title: Sci. Rep.
  doi: 10.1038/srep18992
– volume: 127
  start-page: 16774
  year: 2005
  ident: 69_CR27
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja055762e
– volume: 18
  start-page: 1852
  year: 2017
  ident: 69_CR7
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms18091852
– volume: 9
  start-page: 402
  year: 2013
  ident: 69_CR26
  publication-title: Small
  doi: 10.1002/smll.201201377
– volume: 8
  year: 2017
  ident: 69_CR6
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-01174-3
– volume: 2014
  start-page: 1
  year: 2014
  ident: 69_CR13
  publication-title: Biomed. Res. Int.
  doi: 10.1155/2014/302694
– volume: 50
  start-page: 2321
  year: 2011
  ident: 69_CR10
  publication-title: Biochemistry
  doi: 10.1021/bi101933p
– volume: 1
  start-page: 330
  year: 2002
  ident: 69_CR24
  publication-title: Nitric Oxide-Biol. Chem.
  doi: 10.1006/niox.1997.0141
– volume: 110
  start-page: 145
  year: 1999
  ident: 69_CR9
  publication-title: Toxicol. Lett.
  doi: 10.1016/S0378-4274(99)00160-5
– volume: 344
  start-page: 1492
  year: 2014
  ident: 69_CR19
  publication-title: Science
  doi: 10.1126/science.1242072
– volume: 6
  year: 2016
  ident: 69_CR3
  publication-title: Sci. Rep.
  doi: 10.1038/srep24517
– volume: 11
  start-page: 3199
  year: 2012
  ident: 69_CR22
  publication-title: J. Proteome Res.
  doi: 10.1021/pr2012347
– volume: 10
  year: 2015
  ident: 69_CR25
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0129762
– reference: 22563702 - J Proteome Res. 2012 Jun 1;11(6):3199-210
– reference: 16316209 - J Am Chem Soc. 2005 Dec 7;127(48):16774-5
– reference: 23027505 - Small. 2013 Feb 11;9(3):402-12
– reference: 26075182 - Front Oncol. 2015 May 26;5:115
– reference: 10597025 - Toxicol Lett. 1999 Nov 22;110(3):145-75
– reference: 24599076 - Sci Rep. 2014 Mar 06;4:4297
– reference: 25388936 - Nanotechnology. 2014 Dec 5;25(48):485703
– reference: 24579079 - Biomed Res Int. 2014;2014:302694
– reference: 29093439 - Nat Commun. 2017 Nov 1;8(1):1231
– reference: 27176720 - J Transl Med. 2016 May 12;14(1):133
– reference: 25620181 - J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):717-31
– reference: 14559119 - Biochim Biophys Acta. 2003 Oct 15;1639(2):121-32
– reference: 29348215 - Science. 2018 Jan 19;359(6373):259
– reference: 27193658 - Nature. 2016 May 18;533(7603):304-5
– reference: 24970081 - Science. 2014 Jun 27;344(6191):1492-6
– reference: 29338071 - CA Cancer J Clin. 2018 Mar;68(2):153-165
– reference: 9441905 - Nitric Oxide. 1997 Aug;1(4):330-45
– reference: 26753611 - Sci Rep. 2016 Jan 12;6:18992
– reference: 21355561 - Biochemistry. 2011 Mar 29;50(12):2321-9
– reference: 26061043 - PLoS One. 2015 Jun 10;10(6):e0129762
– reference: 29453278 - Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2467-2472
– reference: 28841158 - Int J Mol Sci. 2017 Aug 25;18(9):null
– reference: 27075165 - Sci Rep. 2016 Apr 14;6:24517
SSID ssj0001851266
Score 2.2005186
Snippet Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma....
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 26
SubjectTerms 692/4028/67/2195
692/53/2421
Cancer
Cancer Research
Cell division
Gene Therapy
Human Genetics
Hydrophobic surfaces
Internal Medicine
Medicine
Medicine & Public Health
Metabolism
Oncology
Precision medicine
Targeted cancer therapy
SummonAdditionalLinks – databaseName: HAS SpringerNature Open Access 2022
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEB7SBPo4lL7SuE3LFnpqWCpL1utoSkMwpJc0kJuYfWGDLQlLoqSn_PTO6JUaQ0oPOu1Ku9LMar7ZmfkW4DP5DOhjGklF1k-SxQtkopyVfLqxcczmorga-fJHdHE9W9yENwcwHWph2qT9ltKy_U0P2WFfKwIOXAw2pcuLUhk_gqOEtJOU-mg-X1wt7jdWCEOQ1RkimEGyf--uDdoDlvv5kWOQ9Bk8afISb3_hev2XHTp_Ac97ACnm3ZRfwoHNX8Hjyz5E_hrurprSbpe3ZluUy0KttCA5yyKXerkqxabbEqxExXCxLjZWMFND0e0Jira8SGBuRF-hVwkU5YDXf1sjOBVd4EjnKQon2DFGGl7UzYZm9wauz7___HYh-2MWpJ7FXi0j55NPFGKEiUt0pJgC3gXWqtDQX1RFyukwtOgC8i2Ul5KPhuj5qZ2FNp05H4NjOMyL3J6AIGNHHgeZu9gYrrHHJLZOaaVjg1obMwFv-PCZ7jnI-SiMddbGwoMk62SVkawyllUWT-DLeEvZEXA81Pl0kGbWr8UqI1CSxpw6Rs2fxmZaRRwawdwWDfWZBkmL1aIJvO2EP44WcNk9IdEJxDtqMXZghu7dlny1bJm6ufgmDWncs0GB7qf1wEucjTr271d-91_Pfg9PfV4HnMeYnsJhvW3sB0JVtfrYr6M_I68fwQ
  priority: 102
  providerName: Springer Nature
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6V9AAceIhXoEWLxIlqg2vHXvtYoVYVEhUSBIWTtU8lIrGt2BZqT_x0ZvyCNFKrHnzaWe3Dszvf7M58C_AefQbpyyTiCq0fR4sX8Fg5y-l1Y-OIzUVRNvKXi-h8Nv08D-d7EPa5ME3QfkNp2WzTfXTYxxKBAyWDHePnRQkXk8K4e7Afheg0j2B_dvH15GfzkFwiOELoeX-DGcS7dbdt0A6w3I2PHC5JH8L9Oivk5W-5Wv1nh84ew49-BG34ya9JXamJvrpG7njnIT6BRx0yZSet4FPYs9kz-POtLuxmcWk2ebHI1VIz1BqeZ1wvlgVbtweMJSsJfFb52jLifcjbE0bWJCsxmRnW5fuVTLKiR_9X1jAKbGdyIAdluWPkZkuDDVX1Grv0HGZnp98_nfPu0Qaup8KreOR89LBCGcnYxTpSRCjvAmtVaHBPVpFyOgytdAF6KspL0OOT0vMTOw1tMnW-DF7AKMsz-woYmk70X9B4CmMoY1_GwjqllRZGam3MGLz-N6a6YzSnhzVWaXOzHsRpO6UpTmlKU5qKMXwYqhQtncdNwge9bqTdyi5ThDiJoEA0LH43FOOapIsWmdm8RpnjIG6QXzSGl60qDa0FlMSPuHYMYkvJBgHi-94uyZaLhvebUnmSENs96tXxX7duGMTRoLG3D_n1naTfwAOf1JWiIpMDGFWb2h4iRqvU225F_gWaVjrC
  priority: 102
  providerName: Unpaywall
Title Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour
URI https://link.springer.com/article/10.1038/s41698-018-0069-7
https://www.ncbi.nlm.nih.gov/pubmed/30480095
https://www.proquest.com/docview/2389720017
https://www.proquest.com/docview/2138639936
https://pubmed.ncbi.nlm.nih.gov/PMC6242957
https://www.nature.com/articles/s41698-018-0069-7.pdf
UnpaywallVersion publishedVersion
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: DOA
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: M~E
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: RPM
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAQT
  databaseName: Springer Nature - nature.com Journals - Fully Open Access
  customDbUrl:
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: NAO
  dateStart: 20171201
  isFulltext: true
  titleUrlDefault: https://www.nature.com/siteindex/index.html
  providerName: Nature Publishing
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: 7X7
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: BENPR
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: HAS SpringerNature Open Access 2022
  customDbUrl:
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: AAJSJ
  dateStart: 20171201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 2397-768X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001851266
  issn: 2397-768X
  databaseCode: C6C
  dateStart: 20171201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1La9tAEB4S-9D2UFr6iNrUbKGnhiWOXisdSnFNQjDUhKYG9yR2tbvYYEuqH5T01J_eGb0cE3AOukgrVquZ3fnmDfAJdQbpyjjkCqUfR4nn8UhZw6m7sbZUzUVRNvL3cXg98UfTYHoE4yYXhsIqmzOxPKh1npKN_BxFSywoAEh8LX5z6hpF3tWmhYasWyvoL2WJsWPo0pHsd6D77XJ882NndUGA4YZVx7lYcMTa08bV6UXna0QnlHF2gVc_jLnYF1YPEOjDQMrWm_oMnmyzQt79kYvFPYF19QKe10iTDSrWeAlHJnsF_263hVnN7vQqL2a5mqcMuYDnGU9n84ItK4Phmq0JTG7ypWFUxyGvLIasTD5iMtOszt9bM8mKBs3_NZpRoDqTbbFPlltGarPUONFmu8RPeg2Tq8ufw2teN2HgqS_6Gx5aFzWmQIYyslEaKioQbz1jVKDxjFWhsmkQGGk91DxUP0YNTsq-Gxs_MLFvXem9gU6WZ-YEGIpC1EdQGAqtKQNfRsJYlapUaKSf1g70m7-dpHWFcmqUsUhKT7kXJRWBEiRQQgRKhAOf21eKqjzHocGnDQmTeqeukx1fOfCxfYx7jBwnMjP5FsdceFGJ5EIH3lYUb2fzKCkfcaoDYo8X2gFUv3v_STaflXW8KTUnDnDes4Zrdp91YBFnLWM9vuR3h5f8Hp66xO0U1hifQmez2poPCLI2qgfHYip60B0MRrejXr2P8O4wHPZKwwXem4xvBr_-A_nXLEM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9FA4IBAvQ4FFggvVqq7fPlSIR6uUthGCVsrN3fWulUiJbWJbVTjxy_htzPgVokrh1ENO3mS9mdmdb3ZmvgF4iz6DsETocYnWj6PFs3kgE82pu7FKiM1FUjXy-cgbXjpfx-54C_50tTCUVtmdifVBrbKY7sj30bSEPiUA-R_yn5y6RlF0tWuhIdrWCuqwphhrCztO9fIaXbji8OQLyvudZR0fXXwe8rbLAI8d3yy5l1joErjCE0ESxJ4kBvTE1lq6Cg8R6ckkdl0tEhuhtTRDdFGEMK1QO64OncQSNv7uHdhG2GE5A9j-dDT69n11y4OAxvKaDnehzxHbj7vQqh3sF4iGqMLtAD-mF3J_3TjeQLw3Ezf76O092KnSXCyvxWz2j4E8fgD3W2TLPjaq-BC2dPoIfv-ocr2YLNUiyyeZnMYMtY5nKY8n05zNmwvKghUEXstsrhnxRmTNDSWri52YSBVr6wULJljeeQ-_tGKUGM9ETy7KsoSRmy4UTlRWc3ylx3B5K-J4AoM0S_UzYGh60f9B4-srRRX_IvB1ImMZ-wr1RSkDzO7fjuKWEZ0ac8yiOjJvB1EjoAgFFJGAIt-A9_1X8oYOZNPg3U6EUXsyFNFKjw140z_GPU2BGpHqrMIxB3ZQI0fPgKeNxPvZbCIBQFxsgL-mC_0A4gtff5JOJzVvOJUChS7Ou9dpzeq1Nixir1es_y_5-eYlv4ad4cX5WXR2Mjp9AXct0nxKqQx3YVAuKv0SAV4pX7W7iMHVbW_cv1_-Y4E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7SFNL2EPrOtmmrQk8NSh17LdvHsO2SPhIKbSA3oye7sGubtU1IT_npmfErXRZSevBJsiV7NJ5vNDOfAD6gzyB9mQiu0PpxtHgBj5WznE43No7YXBRVI5-eiZPz8beL8GILwr4Wpknabygtm990nx32qUTgQMVgR3h5IuHRYWHcPbgfR4EgfZyIye3WCqIItDt9DDOIN-9et0Ib0HIzQ3IIkz6CB3VWyKtLuVj8ZYmmj2G3g5DsuJ30E9iy2VPYOe2C5M_g-ldd2NXsyqzyYparuWYoaZ5nXM_mBVu2m4IlKwkwVvnSMuJqyNtdQdYUGDGZGdbV6JVMsqJH7H-sYZSMzuRA6Mlyx8g1ljg8q-olzu45nE-__J6c8O6gBa7HkVdx4Xz0ikIpZOxiLRSRwLvAWhUa_I8qoZwOQytdgN6F8hL00qT0_MSOQ5uMnS-DF7Cd5ZndA4bmDn0ONHiRMVRlL-PIOqWVjozU2pgReP2HT3XHQk6HYSzSJhoexGkrqxRllZKs0mgEH4dbipaC467O-700004byxRhSRJR8hg2vx-aUY8oOCIzm9fY5yiIG7QmRvCyFf4wWkCF94hFRxCtLYuhA3F0r7dk81nD1U3lN0mI4x70C-h2Wne8xMGwxv79yq_-69nvYOfn52n64-vZ99fw0CeVoKTGZB-2q1Vt3yDEqtTbRqFuABUSIl4
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6V9AAceIhXoEWLxIlqg2vHXvtYoVYVEhUSBIWTtU8lIrGt2BZqT_x0ZvyCNFKrHnzaWe3Dszvf7M58C_AefQbpyyTiCq0fR4sX8Fg5y-l1Y-OIzUVRNvKXi-h8Nv08D-d7EPa5ME3QfkNp2WzTfXTYxxKBAyWDHePnRQkXk8K4e7Afheg0j2B_dvH15GfzkFwiOELoeX-DGcS7dbdt0A6w3I2PHC5JH8L9Oivk5W-5Wv1nh84ew49-BG34ya9JXamJvrpG7njnIT6BRx0yZSet4FPYs9kz-POtLuxmcWk2ebHI1VIz1BqeZ1wvlgVbtweMJSsJfFb52jLifcjbE0bWJCsxmRnW5fuVTLKiR_9X1jAKbGdyIAdluWPkZkuDDVX1Grv0HGZnp98_nfPu0Qaup8KreOR89LBCGcnYxTpSRCjvAmtVaHBPVpFyOgytdAF6KspL0OOT0vMTOw1tMnW-DF7AKMsz-woYmk70X9B4CmMoY1_GwjqllRZGam3MGLz-N6a6YzSnhzVWaXOzHsRpO6UpTmlKU5qKMXwYqhQtncdNwge9bqTdyi5ThDiJoEA0LH43FOOapIsWmdm8RpnjIG6QXzSGl60qDa0FlMSPuHYMYkvJBgHi-94uyZaLhvebUnmSENs96tXxX7duGMTRoLG3D_n1naTfwAOf1JWiIpMDGFWb2h4iRqvU225F_gWaVjrC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Superhydrophobic+lab-on-chip+measures+secretome+protonation+state+and+provides+a+personalized+risk+assessment+of+sporadic+tumour&rft.jtitle=NPJ+precision+oncology&rft.au=Malara%2C+N.&rft.au=Gentile%2C+F.&rft.au=Copped%C3%A8%2C+N.&rft.au=Coluccio%2C+M.+L.&rft.date=2018-11-19&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2397-768X&rft.volume=2&rft_id=info:doi/10.1038%2Fs41698-018-0069-7&rft_id=info%3Apmid%2F30480095&rft.externalDocID=PMC6242957
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2397-768X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2397-768X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2397-768X&client=summon